Skip to main content
SpringerLink
Log in

Earlier Chemotherapy for Breast Cancer: Perhaps Too Late But Still Useful

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727–33.

    PubMed  CAS  Google Scholar 

  2. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T. Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 1978;41:2088–98.

    Article  PubMed  CAS  Google Scholar 

  3. Petit T, Borel C, Theobald S, et al. Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancer. Ann Surg Oncol 2003;10:369–75.

    Article  PubMed  Google Scholar 

  4. Scholl SM, Asselain B, Palangie T, et al. Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer 1991;27:1668–71.

    Article  PubMed  CAS  Google Scholar 

  5. Mauriac L, Durand M, Avril A, Dilhuydy JM. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Ann Oncol 1991;2:347–54.

    PubMed  CAS  Google Scholar 

  6. Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998;16:93–100.

    PubMed  CAS  Google Scholar 

  7. Makris A, Powles TJ, Ashley SE, et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 1998;9:1179–84.

    Article  PubMed  CAS  Google Scholar 

  8. Scholl SM, Fourquet A, Asselain B, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer 1994;30A:645–52.

    Article  PubMed  CAS  Google Scholar 

  9. Mauriac L, MacGrogan G, Avril A, et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 1999;10:47–52.

    Article  PubMed  CAS  Google Scholar 

  10. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672–85.

    PubMed  CAS  Google Scholar 

  11. Scholl SM, Pierga JY, Asselain B, et al. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 1995;31A:1969–75.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Virginia Commonwealth University Health System, Richmond, Virginia

    Harry D. Bear MD, PhD

  2. Division of Surgical Oncology, Virginia Commonwealth University Health System, P.O. Box 980011, Richmond, VA, 23298-0011

    Harry D. Bear MD, PhD

Authors
  1. Harry D. Bear MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harry D. Bear MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bear, H.D. Earlier Chemotherapy for Breast Cancer: Perhaps Too Late But Still Useful. Ann Surg Oncol 10, 334–335 (2003). https://doi.org/10.1245/ASO.2003.02.023

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.02.023

Search

Navigation